Month: February 2025

🚀 Next Crypto Bull Run: Top US-Made Coins That Could Be TAX-FREE!

Join Locals for exclusive content https://sonofatech.locals.com/ Check out the Crypto Mining Ecourse at https://sonofatech.com Ergo Address: 9fCyhudURbDSA2qi9k3sh1LgbHwyFwT6fck7wQW2YYWk9xR1miN ETH Address: 0x8446b70aA05c811d7bF590e6EDE3d90C00391FcE ETC Address: 0x8446b70aA05c811d7bF590e6EDE3d90C00391FcE ZIL Address: zil135ajqdgf9mj6r50e8t28p98xvsss8ay7cppyx5 RVN Address: RLS9LQQg3JyjZV8p2DigMrK3S2qR8syax2 BTC Address: bc1qrk5gvvcxnvaatl9eek8pld6xs5sw0c24tgaenp KAS Address: kaspa:qzwqvpqnxnnfy7y8zdllms68yxvh9htt74rgytn0yjlwlydwcsvjgn0cz0fz6 Flux Address: t1a276Sn6AALj6ifkgMBi8cuxa2415UajsW LTC Address: LbNTMKfnGVoBktK1v4MtGpsoXaECRzQ1sT XMR: 4AG3vNVkPaZ5syjKRfaHNE6CJeZ3e1g3w6pwTTZsLZXYFEpcnZtKX5TQQ6WQ2gNUQ7YVQCXP7apcvigmZvuYLgX97YLmaTa Affiliate Links SimpleMiningOS: https://simplemining.net/ref?user=sonofatech Octominer: https://octominer.com/?aff=blindrun...
Read More

Dogecoin ETF Race Intensifies As Grayscale Joins The Chase

In an exciting development, the race for the Dogecoin ETF in the US is gaining serious momentum as prominent asset manager Grayscale has now joined the fray. Grayscale Seeks To Convert Dogecoin Trust To ETF On Friday, Grayscale announced the launch of a new Dogecoin Trust aimed at granting...
Read More

Crypto VC Money is BACK?! This Changes EVERYTHING!

For better or worse, Venture Capitalists (or VCs) are a crucial part of crypto’s development. The problem is, VCs don’t seem to be as enthusiastic about crypto as they were back in 2021. Naturally, this has everybody wondering what VCs are up to, and what could happen next. Thankfully,...
Read More

Overcoming the ‘Valley of Death:’ How DeSci Reshapes Scientific Research

The scientific research process faces major hurdles, especially in converting basic research into real-world applications through translational research. The “Valley of Death” results in 80-90% of research projects failing before reaching human trials, with only 0.1% of drug candidates becoming approved treatments. Misaligned incentives among academia, funding organizations, and...
Read More